Evolent Health, which provides advisory services and an IT platform to help health systems adopt an outcomes-based business model, raised $195.5 million in an upsized IPO by offering 11.5 million shares at $17, above the range of $14 to $16. The company originally planned to offer 10 million shares. Evolent Health plans to list on the NYSE under the symbol EVH. Evolent Health initially filed confidentially on 12/24/2014. J.P. Morgan and Goldman Sachs acted as lead managers on the deal.
Will this up-priced IPO have a healthy outcome? Evolent prices IPO above range $EVH $IPO #IPO http://t.co/YCkHVebvvH pic.twitter.com/MtOgikzKUE
— Renaissance Capital (@IPOtweet) June 5, 2015
